Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

The Immune Tolerance Institute

2007 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Provider of research, development and drug discovery services for prevention of autoimmune diseases. The company is focused on the development of new therapies for the treatment of various diseases related to the human immune system, including autoimmune diseases, allergy, asthma, cancer and cardiovascular and infectious diseases.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Biotechnology
Acquirer
The David H. Murdock Research Institute
Primary Office
  • 1430 Obrien Drive
  • Suite F
  • Menlo Park, CA 94025
  • United States

The Immune Tolerance Institute Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore The Immune Tolerance Institute‘s full profile, request access.

Request full access to PitchBook